• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Euro Surveill. Association of D222G substitution in haemagglutinin of 2009 pandemic influenza A (H1N1) with severe disease

Giuseppe

Emeritus
Association of D222G substitution in haemagglutinin of 2009 pandemic influenza A (H1N1) with severe disease (Euro Surveill., extract, edited)

[Source: EuroSurveillance.org, <cite cite="http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19534"></cite>Eurosurveillance - View Article. Edited.]

Eurosurveillance, Volume 15, Issue 14, 08 April 2010 - Letters

Association of D222G substitution in haemagglutinin of 2009 pandemic influenza A (H1N1) with severe disease

G C Mak 1, K W Au 1, L S Tai 1, K C Chuang 1, K C Cheng 1, T C Shiu 1, W Lim 1

1. Centre for Health Protection, Department of Health, Hong Kong SAR

Citation style for this article: Mak GC, Au KW, Tai LS, Chuang KC, Cheng KC, Shiu TC, Lim W. Association of D222G substitution in haemagglutinin of 2009 pandemic influenza A (H1N1) with severe disease. Euro Surveill. 2010;15(14):pii=19534. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19534

Date of submission: 01 April 2010


To the editor:

The preferential binding of influenza virus to sialic acid-α2,3-galactose (α2,3 receptor) or sialic acid-α2,6-galactose (α2,6 receptors) may determine its tropism as α2,3 and α2,6 receptors are dominant on lower and upper respiratory cells respectively [1]. The recent glycan microarray analysis suggested that the haemagglutinin (HA) D222G substitution could cause a shift from α2,6 receptors to the mixed α2,3/α2,6 receptors specificity which might increase binding to α2,3 receptors [2] and contribute to severity of disease. This substitution in the HA gene has been reported in samples of viruses obtained from cases with mild to severe illness from around 20 countries, areas and territories [3]. A recent study from Norway has evaluated the clinical relevance of this substitution with severe and mild cases [4].In an attempt to understand the relevance of HA D222G substitution among pandemic influenza A (H1N1) causing infections in Hong Kong, HA gene sequences from respiratory specimens and virus isolates of severe and non-severe cases were examined. Cases were individuals who had laboratory confirmed pandemic H1N1 influenza virus by either viral culture or reverse transcription PCR (RT-PCR) of respiratory specimens [5]. The severe cases were individuals classified by the attending physician as being in a serious or critical condition.

(...)
-
------
 
Back
Top Bottom